Tok, Fatih published the artcileSynthesis and biological evaluation of new pyrazolone Schiff bases as monoamine oxidase and cholinesterase inhibitors, HPLC of Formula: 61343-99-5, the main research area is monoamine oxidase cholinesterase inhibitor pyrazolone Schiff base preparation neurodegeneration; Acetylcholinesterase; Butyrylcholinesterase; Docking; Monoamine oxidase A; Monoamine oxidase B; Schiff base.
In the current work, Schiff base derivatives of antipyrine were synthesized. The chem. characterization of the compounds was confirmed using IR, 1H NMR, 13C NMR and mass spectroscopies. The inhibitory potency of synthesized compounds was investigated towards acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), and monoamine oxidases A and B (MAO-A and MAO-B) enzymes. Some of the compounds displayed significant inhibitory activity against AChE and MAO-B enzymes, resp. According to AChE enzyme inhibition assay, compounds 3e and 3g were found as the most potent derivatives with IC50 values of 0.285 μM and 0.057 μM, resp. Also, compounds 3a (IC50 = 0.114 μM), 3h (IC50 = 0.049 μM), and 3i (IC50 = 0.054 μM) were the most active derivatives against MAO-B enzyme activity. To understand inhibition type, enzyme kinetics studies were carried out. Furthermore, mol. docking studies were performed to define and evaluate the interaction mechanism between compounds 3g and 3h and related enzymes. ADME (Absorption, Distribution, Metabolism, and Excretion) and BBB (Blood, Brain, Barrier) permeability predictions were applied to estimate pharmacokinetic profiles of synthesized compounds
Bioorganic Chemistry published new progress about Cholinesterase inhibitors (acetylcholinesterase, butyrylcholinesterase). 61343-99-5 belongs to class chlorides-buliding-blocks, name is 4-(4-Chlorophenoxy)benzaldehyde, and the molecular formula is C13H9ClO2, HPLC of Formula: 61343-99-5.
Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics